During the past decade, Mount Sinai Comprehensive Cancer Center conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 31 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 24 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 57 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 3 trials as a collaborator and "GOG Foundation" with 3 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Comprehensive Cancer Center" are "Melanoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Lymphoma" (5 trials), "Metastatic Melanoma" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Mount Sinai Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Mount Sinai Comprehensive Cancer Center" are "Drug" (118 trials), "Biological" (45 trials), "Other" (39 trials), "Procedure" (26 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (18 trials), "Quality-of-Life Assessment" (17 trials), "Nivolumab" (15 trials), "Biospecimen Collection" (14 trials) and "Placebo" (14 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Comprehensive Cancer Center" are 126 trials for "All" genders, 11 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Mount Sinai Comprehensive Cancer Center". undefined are not yet recruiting, 38 are recruiting, 45 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 43 completed trials in Mount Sinai Comprehensive Cancer Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Comprehensive Cancer Center, 17 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".